IVERIC bio, Inc. Proceeds from Issuance Initial Public Offering
IVERIC bio, Inc. reported Proceeds from Issuance Initial Public Offering of $175.56 million for the 87-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2014-08-06
- IVERIC bio, Inc. proceeds from issuance initial public offering for the quarter ending 2014-03-31 was $0.00.
- IVERIC bio, Inc. proceeds from issuance initial public offering for the quarter ending 2013-12-31 was $0.00.
- IVERIC bio, Inc. proceeds from issuance initial public offering for fiscal 2013 was $175.56M.
| Period end | Proceeds from Issuance Initial Public Offering 0 month | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month | Proceeds from Issuance Initial Public Offering 81 month | Proceeds from Issuance Initial Public Offering 84 month | Proceeds from Issuance Initial Public Offering 87 month |
|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 derived: 10-Q 87 month − 10-K 84 month · filed 2014-05-13 | $0.00 derived: sum of 2 quarters · filed 2014-05-13 | $175.56M 10-Q · filed 2014-05-13 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $175.56M 10-K · filed 2014-03-11 | $175.56M 10-K · filed 2014-03-11 | |||||
| 2013-09-30 | $175.60M 10-Q · filed 2014-08-06 | $175.56M 10-Q · filed 2013-11-13 | $175.56M 10-Q · filed 2013-11-13 |